Reducing allogeneic transfusion in cardiac surgery: a randomized double-blind placebo-controlled trial of antifibrinolytic therapies used in addition to intra-operative cell salvage.

Reducing allogeneic transfusion in cardiac surgery: a randomized double-blind placebo-controlled trial of antifibrinolytic therapies used in addition to intra-operative cell salvage.

Item
http://www.wikidata.org/entity/Q45182934
Methods to decrease blood loss and transfusion requirements for liver transplantationAnti-fibrinolytic use for minimising perioperative allogeneic blood transfusionEffect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysisThe impact of administration of tranexamic acid in reducing the use of red blood cells and other blood products in cardiac surgeryManagement of bleeding following major trauma: an updated European guideline.Recombinant factor VII is associated with worse survival in complex cardiac surgical patientsManagement of bleeding following major trauma: a European guideline.Aprotinin in cardiac surgery.Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: a case control study followed by a randomized double-blind controlled trial.The effect of antifibrinolytic prophylaxis on postoperative outcomes in patients undergoing cardiac operations.Impact of intra-operative cell salvage on blood coagulation in high-bleeding-risk patients undergoing cardiac surgery with cardiopulmonary bypass: a prospective randomized and controlled trial.Systematic review, meta-analysis and meta-regression of the effect of tranexamic acid on surgical blood loss.Association between CK-MB Area Under the Curve and Tranexamic Acid Utilization in Patients Undergoing Coronary Artery Bypass Surgery.Evaluating the 'next generation' of cell salvage--will it make a difference?Reduction of allogeneic red blood cell usage during cardiac surgery by an integrated intra- and postoperative blood salvage strategy: results of a randomized comparison.A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery.Does use of cell saver decrease the inflammatory response in cardiac surgery?
P2860

Reducing allogeneic transfusion in cardiac surgery: a randomized double-blind placebo-controlled trial of antifibrinolytic therapies used in addition to intra-operative cell salvage.

Item
http://www.wikidata.org/entity/Q45182934
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Reducing allogeneic transfusio ...... intra-operative cell salvage.
@en
Reducing allogeneic transfusio ...... intra-operative cell salvage.
@nl
type
label
Reducing allogeneic transfusio ...... intra-operative cell salvage.
@en
Reducing allogeneic transfusio ...... intra-operative cell salvage.
@nl
prefLabel
Reducing allogeneic transfusio ...... intra-operative cell salvage.
@en
Reducing allogeneic transfusio ...... intra-operative cell salvage.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Reducing allogeneic transfusio ...... intra-operative cell salvage.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921